A benefit-cost analysis of syringe exchange programs

Research output: Contribution to journalArticleResearchpeer-review

8 Citations (Scopus)

Abstract

To date, a paucity of systematic economic evaluations have been applied to syringe exchange programs. In today's cost-conscious environment, with public health officials contending with restricted HIV prevention budgets, what amount of scarce resources should be allocated toward the operation of SEPs? To address this question, benefit-cost analyses emerge as useful strategies to inform decision-makers about which programs hold the most promise for preventing HIV infection among intravenous drug users. This review article balances the benefits of HIV prevention via syringe exchange against the costs of operating such programs.

Original languageEnglish
Pages (from-to)41-57
Number of pages17
JournalJournal of Health and Social Policy
Volume11
Issue number4
DOIs
StatePublished - 1 Jan 2000

Fingerprint

Needle-Exchange Programs
cost-benefit analysis
human immunodeficiency virus
Cost-Benefit Analysis
HIV
Costs and Cost Analysis
Syringes
Budgets
costs
Drug Users
drug user
HIV Infections
Public Health
cost
public health
decision maker
budget
drug
resource
evaluation

Keywords

  • Benefit-cost analysis
  • HIV/AIDS
  • Intravenous drug user (IDU)
  • Syringe exchange program (SEP)

Cite this

@article{84a9a0c6fa914ac6af9d2b288eee25c1,
title = "A benefit-cost analysis of syringe exchange programs",
abstract = "To date, a paucity of systematic economic evaluations have been applied to syringe exchange programs. In today's cost-conscious environment, with public health officials contending with restricted HIV prevention budgets, what amount of scarce resources should be allocated toward the operation of SEPs? To address this question, benefit-cost analyses emerge as useful strategies to inform decision-makers about which programs hold the most promise for preventing HIV infection among intravenous drug users. This review article balances the benefits of HIV prevention via syringe exchange against the costs of operating such programs.",
keywords = "Benefit-cost analysis, HIV/AIDS, Intravenous drug user (IDU), Syringe exchange program (SEP)",
author = "Robert Reid",
year = "2000",
month = "1",
day = "1",
doi = "10.1300/J045v11n04_03",
language = "English",
volume = "11",
pages = "41--57",
journal = "Journal of Health and Social Policy",
issn = "0897-7186",
publisher = "Haworth Press Inc.",
number = "4",

}

A benefit-cost analysis of syringe exchange programs. / Reid, Robert.

In: Journal of Health and Social Policy, Vol. 11, No. 4, 01.01.2000, p. 41-57.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - A benefit-cost analysis of syringe exchange programs

AU - Reid, Robert

PY - 2000/1/1

Y1 - 2000/1/1

N2 - To date, a paucity of systematic economic evaluations have been applied to syringe exchange programs. In today's cost-conscious environment, with public health officials contending with restricted HIV prevention budgets, what amount of scarce resources should be allocated toward the operation of SEPs? To address this question, benefit-cost analyses emerge as useful strategies to inform decision-makers about which programs hold the most promise for preventing HIV infection among intravenous drug users. This review article balances the benefits of HIV prevention via syringe exchange against the costs of operating such programs.

AB - To date, a paucity of systematic economic evaluations have been applied to syringe exchange programs. In today's cost-conscious environment, with public health officials contending with restricted HIV prevention budgets, what amount of scarce resources should be allocated toward the operation of SEPs? To address this question, benefit-cost analyses emerge as useful strategies to inform decision-makers about which programs hold the most promise for preventing HIV infection among intravenous drug users. This review article balances the benefits of HIV prevention via syringe exchange against the costs of operating such programs.

KW - Benefit-cost analysis

KW - HIV/AIDS

KW - Intravenous drug user (IDU)

KW - Syringe exchange program (SEP)

UR - http://www.scopus.com/inward/record.url?scp=0033992461&partnerID=8YFLogxK

U2 - 10.1300/J045v11n04_03

DO - 10.1300/J045v11n04_03

M3 - Article

VL - 11

SP - 41

EP - 57

JO - Journal of Health and Social Policy

JF - Journal of Health and Social Policy

SN - 0897-7186

IS - 4

ER -